当前位置:
X-MOL 学术
›
Ann. Surg.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients.
Annals of Surgery ( IF 7.5 ) Pub Date : 2021-9-11 , DOI: 10.1097/sla.0000000000005071 Aaron M Delman 1 , Kevin M Turner 1 , Kamran Safdar 2 , Nadeem Anwar 2 , Latifa S Silski 3 , Tiffany C Lee 1 , Keith Luckett 4 , Madison C Cuffy 3 , Ralph C Quillin 1, 3 , Michael Schoech 2 , Tiffany E Kaiser 3 , Amit Govil 2 , Khurram Bari 2 , Shimul A Shah 1, 3
Annals of Surgery ( IF 7.5 ) Pub Date : 2021-9-11 , DOI: 10.1097/sla.0000000000005071 Aaron M Delman 1 , Kevin M Turner 1 , Kamran Safdar 2 , Nadeem Anwar 2 , Latifa S Silski 3 , Tiffany C Lee 1 , Keith Luckett 4 , Madison C Cuffy 3 , Ralph C Quillin 1, 3 , Michael Schoech 2 , Tiffany E Kaiser 3 , Amit Govil 2 , Khurram Bari 2 , Shimul A Shah 1, 3
Affiliation
The aim of this study was to assess the 1-year safety and effectiveness of HBV Nucleic Acid Test positive (HBV NAT+) allografts in seronegative kidney transplant (KT) and liver transplant (LT) recipients.
中文翻译:
扩大供体库:首次将乙型肝炎病毒 Nat 阳性实体器官同种异体移植物用于血清阴性受体。
本研究的目的是评估 HBV 核酸检测阳性 (HBV NAT+) 同种异体移植物在血清阴性肾移植 (KT) 和肝移植 (LT) 受者中的 1 年安全性和有效性。
更新日期:2021-09-11
中文翻译:
扩大供体库:首次将乙型肝炎病毒 Nat 阳性实体器官同种异体移植物用于血清阴性受体。
本研究的目的是评估 HBV 核酸检测阳性 (HBV NAT+) 同种异体移植物在血清阴性肾移植 (KT) 和肝移植 (LT) 受者中的 1 年安全性和有效性。